stepcare

Official account of the stepcare-trial.

[Tommaso Scquizzato, MD @tscquizzato]

#TAMEtrial just published!

🩸 Does mild hypercapnia (50-55 mmHg) vs normocapnia (35-45 mmHg) improve outcomes in OHCAs admitted to the ICU?

🧠 Good neuro outcome at 6 mo:
43.5% (hypercapnia) vs 44.6% (normocapnia)

🔗 @NEJM https://t.co/2Fhskr76Ge

#CCR23 #ResusTwitter #FOAMcc

[NEJM @NEJM]

#CCR23: In the TAME trial involving patients with coma after out-of-hospital cardiac arrest, a strategy targeting mild hypercapnia for 24 hours did not improve neurologic outcomes at 6 months as compared with targeted normocapnia. https://t.co/4ZxFzWUsno

[TTM2 @ttm2trial]

https://t.co/v6JnHLkcZo
It is with great sadness and with the warmest memories we remember our friend and fellow researcher Professor Paolo Pelosi. Paolo was an essential member of the TTM-trial group from its start more than 15 years ago.

[stepcare @stepcaretrial]

The STEPCARE trial is registered at https://t.co/IdeLWIBGgv! Read more about the SEDCARE, TEMPCARE and MAPCARE at https://t.co/wwjIytqgbG